Money & Business
Nasdaq's Sharp Slide Raises Scrutiny of AI Spending Binge
Investors demand proof that massive capital commitments to AI can pay off
Oceania
Madagascar's gold buyback desks launch under scrutiny
Quatre guichets officiels face à un trafic d'or qui leur échappe vers Dubaï
Latest
Top Stories
-
Money & Business
National Construction Code Pause: 5 Powerful Positive Effects
-
Politics & Governance
Jobs for South Africans: Inside the IFP’s 80/20 Employment Plan
Markets
Loading market data…
-
Money & Business
Eskom Profit 2025: Big Win, Bigger Opportunities
-
Crime & Society
Sudan Human Trafficking: 5 Shocking Facts Exposing the Crisis
-
Money & Business
Sterling Jumps to $1.3352 as UK Jobless Rate Falls to 4.7%
Editor's Picks
-
Politics & Governance
Child Protection Laws: 5 Urgent Calls for Stronger Safeguards
-
Crime & Society
Women Rights Africa: 7 Powerful Steps to End Legal Reservations
-
Politics & Governance
UN Financial Crisis: 5 Critical Challenges World Leaders Must Address Now
Indian Ocean
-
Crime & Society
Ghanaian Journalists Attack: What Must Be Done to Protect now
-
Politics & Governance
Afrikaners US: 5 Shocking Questions About Refugee Status
-
Politics & Governance
Tanzania Forum Suspended: 5 Shocking Facts About Election Censorship
-
Tourism and Island Life
Albania vs England: 9 Critical Lessons From England’s Commanding 2-0 Victory
Investigation reporting coming soon
We're building a team to deliver in-depth journalism. Stay tuned.
5 Things You Need to Know
-
Crime & Society
Amidou Djiba: 5 Shocking Legal Revelations
-
Politics & Governance
South Africa Israel ICJ Case Moves Forward Despite Ceasefire
-
Money & Business
South Africa’s Investment Plan: What It Means for the Future
Oceania
See moreMadagascar's gold buyback desks launch under scrutiny
Quatre guichets officiels face à un trafic d'or qui leur échappe vers Dubaï
Tourism and Island Life
See moreOxford council taps congestion charge funds for staff travel
Ring-fenced charge surplus redirected to NHS and school staff travel perks
Crime & Society
See moreCancer vaccine trial boost lifts MSD and Moderna shares
Personalised mRNA oncology shot faces cost test as investors weigh trial data
Most Read
Long Read
Politics & Governance